LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto Release
- Autores
- Cussa , jorgelina; Juárez, Juliana; Gómez Costa, Marcos Bruno; Anunziata, Oscar Alfreco
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Abstract: Drug-controlled release systems can keep the level of drugs in precise doses in the body above the optimal level and with low toxicity. We propose the nanomaterial LP-SBA-15 as an attractive new host for drug delivery systems due to its high biocompatibility, in vivo biodegradability, and low toxicity. LP-SBA-15/Ketorolac was prepared and characterized by XRD, FTIR, UV-Vis DRS, TEM, and texture analysis, determining the adsorption capacity and its release and achieving the required therapeutic efficacy. The host shows the ordered mesoporous nanochannels with a diameter of 11-12 nm, maintaining the structure with the incorporation of Keto. The mechanism of drug release from the LP-SBA-15 host was evaluated. Different mathematical models were used to adjust the experimental data, the Ritger-Peppas model followed by the Weibull model the best ones. The promising results we obtained for the release of the drug thoroughly using the new material, reaching a rapid initial release rate, and maintaining a constant rate afterward, allow us to maintain the concentration of the drug in the therapeutic efficacy range, applying it largely to the treatment of diseases that require a rapid response.
Fil: Cussa, Jorgelina. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina.
Fil: Juárez, Juliana. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina.
Fil: Gómez Costa, Marcos Bruno. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina.
Fil: Anunziata, Oscar Alfredo. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina.
Peer Reviewed - Fuente
- Volume 13, Issue 3, 2023, 243
- Materia
-
LP-SBA-15
ketorolac tromethamine
Nanostructured host
Drug-delivering device
Nanoscale medicine - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- Attribution-NonCommercial-NoDerivs 2.5 Argentina
- Repositorio
.jpg)
- Institución
- Universidad Tecnológica Nacional
- OAI Identificador
- oai:ria.utn.edu.ar:20.500.12272/15375
Ver los metadatos del registro completo
| id |
RIAUTN_35c0d981794d689c6e6dcc719dd6ee36 |
|---|---|
| oai_identifier_str |
oai:ria.utn.edu.ar:20.500.12272/15375 |
| network_acronym_str |
RIAUTN |
| repository_id_str |
a |
| network_name_str |
Repositorio Institucional Abierto (UTN) |
| spelling |
LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto ReleaseCussa , jorgelinaJuárez, JulianaGómez Costa, Marcos BrunoAnunziata, Oscar AlfrecoLP-SBA-15ketorolac tromethamineNanostructured hostDrug-delivering deviceNanoscale medicineAbstract: Drug-controlled release systems can keep the level of drugs in precise doses in the body above the optimal level and with low toxicity. We propose the nanomaterial LP-SBA-15 as an attractive new host for drug delivery systems due to its high biocompatibility, in vivo biodegradability, and low toxicity. LP-SBA-15/Ketorolac was prepared and characterized by XRD, FTIR, UV-Vis DRS, TEM, and texture analysis, determining the adsorption capacity and its release and achieving the required therapeutic efficacy. The host shows the ordered mesoporous nanochannels with a diameter of 11-12 nm, maintaining the structure with the incorporation of Keto. The mechanism of drug release from the LP-SBA-15 host was evaluated. Different mathematical models were used to adjust the experimental data, the Ritger-Peppas model followed by the Weibull model the best ones. The promising results we obtained for the release of the drug thoroughly using the new material, reaching a rapid initial release rate, and maintaining a constant rate afterward, allow us to maintain the concentration of the drug in the therapeutic efficacy range, applying it largely to the treatment of diseases that require a rapid response.Fil: Cussa, Jorgelina. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina.Fil: Juárez, Juliana. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina.Fil: Gómez Costa, Marcos Bruno. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina.Fil: Anunziata, Oscar Alfredo. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina.Peer ReviewedBiointerface Research in Applied Chemistry2026-08-10T21:04:16Z2023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articulopdfapplication/pdfBiointerface Research in Applied Chemistry2069-5837https://hdl.handle.net/20.500.12272/15375Volume 13, Issue 3, 2023, 243reponame:Repositorio Institucional Abierto (UTN)instname:Universidad Tecnológica Nacionalenginfo:eu-repo/semantics/openAccessAttribution-NonCommercial-NoDerivs 2.5 Argentinahttp://creativecommons.org/licenses/by-nc-nd/2.5/ar/Cussa, Jorgelina; Juárez, Juliana; Gómez Costa, Marcos Bruno; Anunziata, Oscar Alfredo.https://creativecommons.org/licenses/by-nc-nd/4.0/2026-09-24T12:46:33Zoai:ria.utn.edu.ar:20.500.12272/15375instacron:UTNInstitucionalhttp://ria.utn.edu.ar/Universidad públicaNo correspondehttp://ria.utn.edu.ar/oaigestionria@rec.utn.edu.ar; fsuarez@rec.utn.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2026-09-24 12:46:34.032Repositorio Institucional Abierto (UTN) - Universidad Tecnológica Nacionalfalse |
| dc.title.none.fl_str_mv |
LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto Release |
| title |
LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto Release |
| spellingShingle |
LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto Release Cussa , jorgelina LP-SBA-15 ketorolac tromethamine Nanostructured host Drug-delivering device Nanoscale medicine |
| title_short |
LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto Release |
| title_full |
LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto Release |
| title_fullStr |
LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto Release |
| title_full_unstemmed |
LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto Release |
| title_sort |
LP-SBA-15/Ketorolac Nanocomposite: Development, Characterization, and Mathematical Modeling of Controlled Keto Release |
| dc.creator.none.fl_str_mv |
Cussa , jorgelina Juárez, Juliana Gómez Costa, Marcos Bruno Anunziata, Oscar Alfreco |
| author |
Cussa , jorgelina |
| author_facet |
Cussa , jorgelina Juárez, Juliana Gómez Costa, Marcos Bruno Anunziata, Oscar Alfreco |
| author_role |
author |
| author2 |
Juárez, Juliana Gómez Costa, Marcos Bruno Anunziata, Oscar Alfreco |
| author2_role |
author author author |
| dc.subject.none.fl_str_mv |
LP-SBA-15 ketorolac tromethamine Nanostructured host Drug-delivering device Nanoscale medicine |
| topic |
LP-SBA-15 ketorolac tromethamine Nanostructured host Drug-delivering device Nanoscale medicine |
| dc.description.none.fl_txt_mv |
Abstract: Drug-controlled release systems can keep the level of drugs in precise doses in the body above the optimal level and with low toxicity. We propose the nanomaterial LP-SBA-15 as an attractive new host for drug delivery systems due to its high biocompatibility, in vivo biodegradability, and low toxicity. LP-SBA-15/Ketorolac was prepared and characterized by XRD, FTIR, UV-Vis DRS, TEM, and texture analysis, determining the adsorption capacity and its release and achieving the required therapeutic efficacy. The host shows the ordered mesoporous nanochannels with a diameter of 11-12 nm, maintaining the structure with the incorporation of Keto. The mechanism of drug release from the LP-SBA-15 host was evaluated. Different mathematical models were used to adjust the experimental data, the Ritger-Peppas model followed by the Weibull model the best ones. The promising results we obtained for the release of the drug thoroughly using the new material, reaching a rapid initial release rate, and maintaining a constant rate afterward, allow us to maintain the concentration of the drug in the therapeutic efficacy range, applying it largely to the treatment of diseases that require a rapid response. Fil: Cussa, Jorgelina. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina. Fil: Juárez, Juliana. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina. Fil: Gómez Costa, Marcos Bruno. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina. Fil: Anunziata, Oscar Alfredo. Universidad Tecnológica Nacional. Facultad Regional Córdoba. Centro de Investigación Nanociencia y Nanotecnología; Argentina. Peer Reviewed |
| description |
Abstract: Drug-controlled release systems can keep the level of drugs in precise doses in the body above the optimal level and with low toxicity. We propose the nanomaterial LP-SBA-15 as an attractive new host for drug delivery systems due to its high biocompatibility, in vivo biodegradability, and low toxicity. LP-SBA-15/Ketorolac was prepared and characterized by XRD, FTIR, UV-Vis DRS, TEM, and texture analysis, determining the adsorption capacity and its release and achieving the required therapeutic efficacy. The host shows the ordered mesoporous nanochannels with a diameter of 11-12 nm, maintaining the structure with the incorporation of Keto. The mechanism of drug release from the LP-SBA-15 host was evaluated. Different mathematical models were used to adjust the experimental data, the Ritger-Peppas model followed by the Weibull model the best ones. The promising results we obtained for the release of the drug thoroughly using the new material, reaching a rapid initial release rate, and maintaining a constant rate afterward, allow us to maintain the concentration of the drug in the therapeutic efficacy range, applying it largely to the treatment of diseases that require a rapid response. |
| publishDate |
2023 |
| dc.date.none.fl_str_mv |
2023 2026-08-10T21:04:16Z |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
Biointerface Research in Applied Chemistry 2069-5837 https://hdl.handle.net/20.500.12272/15375 |
| identifier_str_mv |
Biointerface Research in Applied Chemistry 2069-5837 |
| url |
https://hdl.handle.net/20.500.12272/15375 |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess Attribution-NonCommercial-NoDerivs 2.5 Argentina http://creativecommons.org/licenses/by-nc-nd/2.5/ar/ Cussa, Jorgelina; Juárez, Juliana; Gómez Costa, Marcos Bruno; Anunziata, Oscar Alfredo. https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivs 2.5 Argentina http://creativecommons.org/licenses/by-nc-nd/2.5/ar/ Cussa, Jorgelina; Juárez, Juliana; Gómez Costa, Marcos Bruno; Anunziata, Oscar Alfredo. https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.format.none.fl_str_mv |
pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Biointerface Research in Applied Chemistry |
| publisher.none.fl_str_mv |
Biointerface Research in Applied Chemistry |
| dc.source.none.fl_str_mv |
Volume 13, Issue 3, 2023, 243 reponame:Repositorio Institucional Abierto (UTN) instname:Universidad Tecnológica Nacional |
| reponame_str |
Repositorio Institucional Abierto (UTN) |
| collection |
Repositorio Institucional Abierto (UTN) |
| instname_str |
Universidad Tecnológica Nacional |
| repository.name.fl_str_mv |
Repositorio Institucional Abierto (UTN) - Universidad Tecnológica Nacional |
| repository.mail.fl_str_mv |
gestionria@rec.utn.edu.ar; fsuarez@rec.utn.edu.ar |
| _version_ |
1877230924510265344 |
| score |
13.265058 |